Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) COO Sells 1,430 Shares of Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,430 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Christian B. Voigtlander also recently made the following trade(s):

• On Monday, November 25th, Christian B. Voigtlander sold 1,962 shares of ICU Medical stock. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96.

ICU Medical Stock Up 1.3 %

ICUI stock opened at $159.75 on Thursday. The business’s 50-day moving average is $175.61 and its two-hundred day moving average is $146.51. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -34.96 and a beta of 0.66. ICU Medical, Inc. has a fifty-two week low of $83.26 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Analyst Upgrades and Downgrades

ICUI has been the topic of several analyst reports. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Jefferies Financial Group initiated coverage on ICU Medical in a report on Monday, October 14th. They set a “hold” rating and a $183.00 price target on the stock. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. KeyCorp upped their target price on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $173.00.

Hedge Funds Weigh In On ICU Medical

A number of institutional investors and hedge funds have recently made changes to their positions in ICUI. Hexagon Capital Partners LLC raised its position in ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 122 shares during the period. Allworth Financial LP raised its holdings in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares during the period. Innealta Capital LLC purchased a new position in ICU Medical during the second quarter valued at $32,000. Venturi Wealth Management LLC increased its position in ICU Medical by 1,510.0% in the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 302 shares in the last quarter. Finally, Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the 3rd quarter valued at approximately $72,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.